Medetomidine-vatinoxan (Zenalpha) results in reduction of systolic function, blood pressure, and heart rate with prolongation of electrocardiographic intervals in healthy dogs
{{output}}
Objective: To determine the effects of medetomidine-vatinoxan (Zenalpha; MVZ) on echocardiographic parameters, blood pressure, and cardiac rhythm in healthy dogs. ... ...
